{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:35:40Z","timestamp":1794980140521,"version":"4.9.1"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"TIPS research fund","award":["S2948352"],"award-info":[{"award-number":["S2948352"]}]},{"DOI":"10.13039\/501100002613","name":"Ulsan National Institute of Science and Technology","doi-asserted-by":"publisher","award":["1.240006.01"],"award-info":[{"award-number":["1.240006.01"]}],"id":[{"id":"10.13039\/501100002613","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002613","name":"Ulsan National Institute of Science and Technology","doi-asserted-by":"publisher","award":["1.240006.01"],"award-info":[{"award-number":["1.240006.01"]}],"id":[{"id":"10.13039\/501100002613","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korean ARPA-H Project","award":["RS-2024-00512120"],"award-info":[{"award-number":["RS-2024-00512120"]}]},{"name":"Korean ARPA-H Project","award":["RS-2024-00512120"],"award-info":[{"award-number":["RS-2024-00512120"]}]},{"name":"Technology Innovation Program","award":["RS-2024-00400101"],"award-info":[{"award-number":["RS-2024-00400101"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Alterations in propanoate metabolism are increasingly recognized as significant biomarkers for various liver disorders, notably hepatocellular carcinoma (HCC). To enhance diagnostic specificity for HCC, we conducted integrated binary omics and targeted metabolomics analyses, identifying liver-specific propanoate metabolism (LPM) gene signatures and associated metabolites. Leveraging data from 40 tissues and 81 cell subclasses, hepatocytes showed the highest metabolic specificity. Clinical validation using the TCGA-LIHC cohort highlighted LPM genes, notably <jats:italic>ALDH2<\/jats:italic> and <jats:italic>ABAT<\/jats:italic>, as robust prognostic markers significantly associated with poor survival outcomes. Serum metabolomic profiling of 273 patients demonstrated that elevated toluene and xylene isomers and significantly reduced 2-ethylhexanol distinctly characterize HCC, distinguishing it from liver cirrhosis, hepatitis, and other cancers. These findings emphasize the potential of LPM-based metabolic profiling as a precise diagnostic and prognostic tool, with potential implications in targeted therapeutic development for HCC.<\/jats:p>","DOI":"10.1186\/s40364-025-00842-7","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:59:29Z","timestamp":1761040769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Liver-specific propanoate metabolism-derived 2-ethylhexanol as a novel biomarker for precise diagnosis and prognosis of hepatocellular carcinoma"],"prefix":"10.1186","volume":"13","author":[{"given":"Dongyong","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhee","family":"Mun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geumjong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonghyuk","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangseock","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taewan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seob","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmyoung","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"3","key":"842_CR1","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jhep.2022.11.017","volume":"78","author":"J Sun","year":"2023","unstructured":"Sun J, et al. Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma. J Hepatol. 2023;78(3):627\u201342.","journal-title":"J Hepatol"},{"issue":"16","key":"842_CR2","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1158\/0008-5472.CAN-13-0308","volume":"73","author":"Q Huang","year":"2013","unstructured":"Huang Q, et al. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics. Cancer Res. 2013;73(16):4992\u20135002.","journal-title":"Cancer Res"},{"issue":"1","key":"842_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ccell.2015.12.004","volume":"29","author":"AA Hakimi","year":"2016","unstructured":"Hakimi AA, et al. An integrated metabolic atlas of clear cell renal cell carcinoma. Cancer Cell. 2016;29(1):104\u201316.","journal-title":"Cancer Cell"},{"issue":"2","key":"842_CR4","doi-asserted-by":"publisher","first-page":"e665","DOI":"10.1002\/ctm2.665","volume":"12","author":"Z Jia","year":"2022","unstructured":"Jia Z, et al. ACSS3 in brown fat drives propionate catabolism and its deficiency leads to autophagy and systemic metabolic dysfunction. Clin Translational Med. 2022;12(2):e665.","journal-title":"Clin Translational Med"},{"issue":"9","key":"842_CR5","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/cac2.12591","volume":"44","author":"Fusheng Zhang","year":"2024","unstructured":"Zhang F et al. Cellular senescence and metabolic reprogramming: unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment. Cancer Commun, 2024;44(9):929\u2013966 https:\/\/doi.org\/10.1002\/cac2.12591","journal-title":"Cancer Communications"},{"issue":"1","key":"842_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/1348-9585.12017","volume":"61","author":"T Wakayama","year":"2019","unstructured":"Wakayama T, et al. Comprehensive review of 2-ethyl-1-hexanol as an indoor air pollutant. J Occup Health. 2019;61(1):19\u201335.","journal-title":"J Occup Health"},{"issue":"2","key":"842_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cac2.12250","volume":"42","author":"L Zhao","year":"2022","unstructured":"Zhao L, et al. Ferroptosis in cancer and cancer immunotherapy. Cancer Commun. 2022;42(2):88\u2013116.","journal-title":"Cancer Commun"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00842-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-025-00842-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00842-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:59:31Z","timestamp":1761040771000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomarkerres.biomedcentral.com\/articles\/10.1186\/s40364-025-00842-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":7,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["842"],"URL":"https:\/\/doi.org\/10.1186\/s40364-025-00842-7","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was approved by UNIST-IRB\u201020\u201007\u2010C and SCH-IRB-2023-10-030.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}